cromakalim has been researched along with Disease Models, Animal in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (38.10) | 18.2507 |
| 2000's | 14 (33.33) | 29.6817 |
| 2010's | 8 (19.05) | 24.3611 |
| 2020's | 4 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Aziz, Q; Christensen, SL; Christensen, ST; Cour, S; Ernstsen, C; Guzaite, G; Hansen, TF; Janfelt, C; Jansen-Olesen, I; Kogelman, LJ; Kristensen, DM; Lauritzen, SP; Olesen, J; Rasmussen, RH; Styrishave, B; Tinker, A | 1 |
| Anderson, KJ; Dosa, PI; Fautsch, MP; Holman, BH; Millar, JC; Roddy, GW; Roy Chowdhury, U | 1 |
| Li, Z; Liu, X; Ren, X; Wang, W; Wang, Y; Wu, S; Zhang, K; Zhu, C | 1 |
| Ashina, M; Christensen, SL; Ernstsen, C; Guo, S; Hay-Schmidt, A; Kristensen, DM; Olesen, J | 1 |
| Hamlin, RL; Kijtawornrat, A; Limprasutr, V; Meedech, P; Saengklub, N | 1 |
| Archondo, T; Chin, A; García-Torrent, MJ; González, P; Macaya, C; Molina-Morúa, R; Moreno, J; Pérez-Castellano, N; Pérez-Villacastín, J; Quintanilla, JG; Rodríguez-Bobada, C; Usandizaga, E | 1 |
| Dong, J; Jia, X; Li, W; Liu, G; Sun, J; Tian, J; Wang, R; Wang, X; Wang, Y; Wei, L; Zhao, G | 1 |
| Dehpour, AR; Ebrahimi, F; Ghasemi, M; Gholipour, T; Karimollah, AR; Nezami, BG; Shafaroodi, H | 1 |
| Bortolatto, CF; Jesse, CR; Nogueira, CW; Wilhelm, EA | 1 |
| Bari, F; Boda, K; Busija, DW; Domoki, F; Institoris, A; Katakam, PV; Snipes, JA | 1 |
| Gao, JY; Ito, K; Ito, Y; Shimokawa, H; Shiroto, T; Tsuburaya, R; Yasuda, S | 1 |
| Amrutkar, DV; Baun, M; Gupta, S; Hay-Schmidt, A; Iversen, A; Jansen-Olesen, I; Lund, TM; Olesen, J; Ploug, KB; Ramachandran, R | 1 |
| Busija, DW; Erdös, B; Miller, AW | 1 |
| Brioni, JD; Brune, ME; Coghlan, MJ; Fey, TA; Gopalakrishnan, M; King, LL; Strake, JG; Sullivan, JP | 1 |
| Brioni, JD; Brune, ME; Coghlan, MJ; Fabiyi, AC; Gopalakrishnan, M; Lynch, JJ | 1 |
| Das, B; Sarkar, C | 1 |
| Endre, ZH; Gobé, GC; Rahgozar, M; Willgoss, DA | 1 |
| Ghosh, M; Hanna, ST; McNeill, JR; Wang, R | 1 |
| Asadi, S; Dehpour, AR; Ebrahimi, F; Ghasemi, M; Hajrasouliha, AR; Sadeghipour, H; Shafaroodi, H; Tavakoli, S | 1 |
| Chen, X; Connors, SG; Mendonca, M; Patel, K; Welch, WJ; Wilcox, CS | 1 |
| Hirano, T; Hisa, H; Ogasawara, A; Satoh, S | 1 |
| Dux, L; Ferdinandy, P; Koltai, M; Szilvássy, Z | 1 |
| Grover, GJ | 1 |
| Carmint, WJ; Colatsky, TJ; Fenichel, RL; Patelunas-Hoffman, DM | 1 |
| Drew, GM; Roach, AG; Trezise, DJ; Watts, IS; Weston, AH | 1 |
| Imagawa, J; Kamei, K; Koga, T; Nabata, H; Sugo, I; Yoshida, S | 1 |
| Chapman, ID; Cook, NS | 1 |
| Brotchie, JM; Crossman, AR; Duty, S; Hille, CJ; Maneuf, YP | 1 |
| Baczkó, I; Leprán, I; Papp, JG | 1 |
| Koyama, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M | 1 |
| Abe, A; Kawazoe, C; Kondo, Y; Sato, K | 1 |
| Astier, A; Baufreton, C; Bertrand, S; Fernandez, C; Garnier, JP; Kirsch, M; Loisance, D | 1 |
| Du Plooy, WJ; Hay, L; Kahler, CP; Schutte, PJ | 1 |
| Abe, I; Fujii, K; Fujishima, M; Goto, K; Onaka, U | 1 |
| Armstead, WM | 1 |
| Ambalavanan, N; Bulger, A; Philips, J; Ware, J | 1 |
| Leerssen, HM; Leunissen, JD; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ; Winckels, SK | 1 |
| Aitken, S; De Jonckheere, B; McCaig, DJ | 1 |
| Kamijo, T; Kido, H; Miwa, A; Nakamura, F; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
| Colatsky, TJ; Harvey, C; Kitzen, JM; McCallum, JD; Morin, ME; Oshiro, GT | 1 |
| Hamilton, TC; Longman, SD | 1 |
| Bhattacharjee, S; Kraft, P; Li, X; Lundeen, SG; Qiu, Y; Sui, Z; Woods, M; Zhang, X | 1 |
2 review(s) available for cromakalim and Disease Models, Animal
| Article | Year |
|---|---|
Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dihydropyridines; Disease Models, Animal; Dogs; Guanidines; Guinea Pigs; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Rats; Vasodilator Agents | 1994 |
Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Cardiovascular System; Central Nervous System; Clinical Trials as Topic; Cromakalim; Disease Models, Animal; Guanidines; Humans; Muscle, Smooth, Vascular; Muscles; Neurons; Niacinamide; Nicorandil; Pancreas; Pinacidil; Potassium Channels; Pyrroles; Vasodilator Agents | 1992 |
40 other study(ies) available for cromakalim and Disease Models, Animal
| Article | Year |
|---|---|
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models.
Topics: Adenosine Triphosphate; Animals; Cromakalim; Disease Models, Animal; Humans; KATP Channels; Mice; Mice, Knockout; Migraine Disorders; Muscle, Smooth; RNA, Messenger | 2022 |
Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models.
Topics: Animals; Antihypertensive Agents; Cromakalim; Diazoxide; Disease Models, Animal; Eye; Intraocular Pressure; KATP Channels; Mice; Mice, Inbred DBA; Microscopy, Electron, Transmission; Ocular Hypertension; Ophthalmic Solutions | 2022 |
A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cromakalim; Disease Models, Animal; Humans; Hyperalgesia; Mice; Migraine Disorders; Nitroglycerin; Pain; Proto-Oncogene Proteins c-fos; Receptors, Calcitonin Gene-Related Peptide | 2022 |
PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine.
Topics: Animals; Calcitonin Gene-Related Peptide; Cromakalim; Disease Models, Animal; Drug Hypersensitivity; Mice; Migraine Disorders; Nitroglycerin; Pituitary Adenylate Cyclase-Activating Polypeptide; Signal Transduction; Sumatriptan | 2022 |
Characteristics of electromechanical window in anesthetized rabbit models of short QT and long QT syndromes.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Benzopyrans; Biomarkers; Biomarkers, Pharmacological; Cromakalim; Disease Models, Animal; Electrocardiography; Isoflurane; Long QT Syndrome; Phenethylamines; Pinacidil; Quinidine; Rabbits; Risk; Sulfonamides; Systole; Torsades de Pointes; Ventricular Pressure | 2017 |
KATP channel opening accelerates and stabilizes rotors in a swine heart model of ventricular fibrillation.
Topics: Animals; Cromakalim; Disease Models, Animal; Electrophysiological Phenomena; Humans; In Vitro Techniques; KATP Channels; Models, Cardiovascular; Sus scrofa; Ventricular Fibrillation; Voltage-Sensitive Dye Imaging | 2013 |
The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation.
Topics: Adrenergic beta-3 Receptor Agonists; Animals; Atrial Fibrillation; Atrial Remodeling; Cromakalim; Disease Models, Animal; Dogs; Female; Heart Atria; Nitric Oxide Synthase Type II; Oxidative Stress; Receptors, Adrenergic, beta-3 | 2016 |
ATP-sensitive potassium channels contribute to the time-dependent alteration in the pentylenetetrazole-induced seizure threshold in diabetic mice.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Cromakalim; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Glyburide; Hypoglycemic Agents; KATP Channels; Male; Mice; Parasympatholytics; Pentylenetetrazole; Seizures; Time Factors | 2010 |
Role of different types of potassium channels and peroxisome proliferator-activated receptors γ in the antidepressant-like activity of bis selenide in the mouse tail suspension test.
Topics: Analysis of Variance; Anilides; Animals; Antidepressive Agents; Behavior, Animal; Cromakalim; Disease Models, Animal; Exploratory Behavior; Freezing Reaction, Cataleptic; Hindlimb Suspension; Male; Mice; Organoselenium Compounds; Potassium Channel Blockers; Potassium Channels; PPAR gamma | 2011 |
Impaired vascular responses of insulin-resistant rats after mild subarachnoid hemorrhage.
Topics: Acetylcholine; Animals; Cerebrovascular Circulation; Cromakalim; Cyclooxygenase 2; Disease Models, Animal; Insulin Resistance; Nitroprusside; Obesity; Rats; Rats, Zucker; Subarachnoid Hemorrhage; Vasodilation; Vasodilator Agents; Vasospasm, Intracranial | 2011 |
Eicosapentaenoic acid reduces ischemic ventricular fibrillation via altering monophasic action potential in pigs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cromakalim; Disease Models, Animal; Eicosapentaenoic Acid; Fatty Acids; Gene Expression Regulation; Male; Myocardial Ischemia; Parasympatholytics; Potassium Channels, Inwardly Rectifying; Swine; Ventricular Fibrillation | 2011 |
K(ATP) channel openers in the trigeminovascular system.
Topics: Animals; ATP-Binding Cassette Transporters; Calcitonin Gene-Related Peptide; Cell Degranulation; Cromakalim; Diazoxide; Disease Models, Animal; Dura Mater; KATP Channels; Male; Mast Cells; Migraine Disorders; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Receptors, Drug; Sulfonylurea Receptors; Trigeminal Caudal Nucleus; Trigeminal Ganglion; Vasodilator Agents | 2012 |
Alterations in KATP and KCa channel function in cerebral arteries of insulin-resistant rats.
Topics: Adenosine Triphosphate; Animals; Bradykinin; Calcium; Cerebral Arteries; Cromakalim; Disease Models, Animal; Dose-Response Relationship, Drug; Fructose; Hyperinsulinism; Hyperlipidemias; Hypertriglyceridemia; In Vitro Techniques; Insulin Resistance; Lipoproteins, HDL; Male; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2002 |
Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction.
Topics: Adenosine Triphosphate; Animals; Benzhydryl Compounds; Benzoxazines; Cresols; Cromakalim; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ion Channel Gating; Muscarinic Antagonists; Muscle Contraction; Oxazines; Parasympatholytics; Phenylpropanolamine; Potassium Channels; Sus scrofa; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2003 |
In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel openers (-)-cromakalim, ZD6169 and WAY-133537 in rats.
Topics: Amides; Animals; Benzophenones; Calcium Channels; Cromakalim; Cyclobutanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Male; Muscarinic Antagonists; Muscle Contraction; Nitriles; Rats; Rats, Sprague-Dawley; Reflex, Abnormal; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Neurogenic; Vasodilator Agents | 2003 |
Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Cromakalim; Decanoic Acids; Disease Models, Animal; Glutathione; Heart Rate; Hydroxy Acids; Male; Malondialdehyde; Membrane Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Nicorandil; Oxidative Stress; Potassium Channels; Rabbits; Sarcolemma; Sulfonamides; Superoxide Dismutase; Survival Rate; Thiourea | 2003 |
ATP-dependent K+ channels in renal ischemia reperfusion injury.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Cromakalim; Diazoxide; Disease Models, Animal; Glomerular Filtration Rate; Glyburide; Kidney; Kidney Function Tests; Male; Organ Culture Techniques; Potassium Channels; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Reperfusion Injury; Sensitivity and Specificity | 2003 |
Altered vascular reactivity and KATP channel currents in vascular smooth muscle cells from deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Blood Pressure; Canada; Cromakalim; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Implants; Electrophysiology; Endothelium, Vascular; Glyburide; Hypertension; Male; Membrane Potentials; Muscle, Smooth, Vascular; Nephrectomy; Phenylephrine; Potassium Channels; Potassium Chloride; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasodilation | 2004 |
Role of ATP-sensitive potassium channels in the biphasic effects of morphine on pentylenetetrazole-induced seizure threshold in mice.
Topics: Adenosine Triphosphate; Animals; Behavior, Animal; Blood Glucose; Cromakalim; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; Hypoglycemic Agents; Male; Mice; Morphine; Narcotics; Pentylenetetrazole; Potassium Channels; Seizures; Severity of Illness Index | 2007 |
Acute antihypertensive action of Tempol in the spontaneously hypertensive rat.
Topics: Amitrole; Animals; Antihypertensive Agents; Blood Pressure; Buthionine Sulfoximine; Catalase; Cromakalim; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ganglionic Blockers; Glutathione Peroxidase; Glyburide; Heart Rate; Heme Oxygenase (Decyclizing); Hexamethonium; Hypertension; Infusions, Intravenous; KATP Channels; Large-Conductance Calcium-Activated Potassium Channels; Male; Metalloporphyrins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptides; Potassium Channel Blockers; Rats; Rats, Inbred SHR; Spin Labels; Sympathetic Nervous System; Time Factors | 2007 |
Cromakalim suppresses hypertonic saline-induced renal vasoconstriction in anaesthetized dogs.
Topics: Animals; Benzopyrans; Cromakalim; Disease Models, Animal; Diuresis; Dogs; Female; Glomerular Filtration Rate; Hematocrit; Male; Potassium Channels; Pyrroles; Renal Circulation; Saline Solution, Hypertonic; Sodium; Vasoconstriction; Vasodilator Agents | 1995 |
Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts.
Topics: Animals; Benzopyrans; Blood Pressure; Cardiac Pacing, Artificial; Coronary Circulation; Cromakalim; Disease Models, Animal; Glyburide; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vasodilator Agents | 1995 |
Analysis of the potassium channel openers celikalim, pinacidil and cromakalim in platelet models of thrombosis.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Blood Coagulation; Cromakalim; Disease Models, Animal; Evaluation Studies as Topic; Guanidines; Humans; Indoles; Male; Molecular Structure; Pinacidil; Platelet Aggregation Inhibitors; Potassium Channels; Pyrroles; Rabbits; Stereoisomerism; Thrombosis | 1994 |
Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia.
Topics: Animals; Benzopyrans; Blood Pressure; Cromakalim; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Heart Rate; Hindlimb; Ischemia; Male; Muscle Contraction; Muscles; Pyrroles; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasodilator Agents | 1993 |
In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
Topics: Administration, Inhalation; Albuterol; Anesthesia; Animals; Antigens; Asthma; Benzopyrans; Bronchoconstriction; Bronchodilator Agents; Consciousness; Cromakalim; Disease Models, Animal; Guinea Pigs; Histamine; Immunization; Injections, Intravenous; Male; Potassium Channels; Pyrroles | 1994 |
Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma.
Topics: Animals; Asthma; Benzopyrans; Cromakalim; Cyclopentanes; Disease Models, Animal; Humans; Parasympatholytics; Peripheral Vascular Diseases; Potassium Channels; Pyrroles; Rats | 1993 |
Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Benzopyrans; Cromakalim; Diazoxide; Disease Models, Animal; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; Ion Channel Gating; Locomotion; Male; Parkinson Disease; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Reserpine; Time Factors | 1996 |
KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
Topics: Action Potentials; Adenosine Triphosphate; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzopyrans; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Cromakalim; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Glyburide; Guanidines; Heart Rate; Male; Myocardial Reperfusion Injury; Pinacidil; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Survival Rate; Vasodilator Agents; Ventricular Fibrillation | 1997 |
Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Circulation; Cromakalim; Disease Models, Animal; Dogs; Female; Heart; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Niacinamide; Nicorandil; Nitroglycerin; Saponins; Vasodilator Agents | 1998 |
Vascular responsiveness in alloxan-induced diabetes-susceptible (ALS) and resistant (ALR) mice.
Topics: Alloxan; Animals; Blood Glucose; Cromakalim; Diabetes Mellitus, Experimental; Dinoprost; Disease Models, Animal; Disease Susceptibility; Glycosuria; Male; Mice; Muscle, Smooth, Vascular; Nitroprusside; Norepinephrine; Potassium; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1998 |
Pretreatment with a potassium-channel opener before prolonged cardiac storage: an evaluation in an experimental brain death model.
Topics: Animals; Brain Death; Coronary Circulation; Creatine Kinase; Cromakalim; Disease Models, Animal; Epinephrine; Evaluation Studies as Topic; Ischemic Preconditioning, Myocardial; Norepinephrine; Organ Preservation; Organ Preservation Solutions; Rabbits; Vasodilator Agents | 1999 |
The role of cromakalim and a nitric oxide synthase blocker in cardiac arrhythmia in the intact baboon model.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Catheterization; Cromakalim; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Hemodynamics; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Papio; Propranolol; Time Factors | 2000 |
Renin-angiotensin system blockade improves endothelial dysfunction in hypertension.
Topics: Acetylcholine; Administration, Oral; Angiotensin Receptor Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzimidazoles; Biological Factors; Biphenyl Compounds; Cromakalim; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Indomethacin; Male; Nitroarginine; Norepinephrine; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles | 2000 |
Vasopressin-induced protein kinase C-dependent superoxide generation contributes to atp-sensitive potassium channel but not calcium-sensitive potassium channel function impairment after brain injury.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Arteries; Benzimidazoles; Brain Injuries; Brain Ischemia; Calcitonin Gene-Related Peptide; Cromakalim; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Female; Male; Pia Mater; Potassium Channels; Protein Kinase C; Superoxides; Swine; Vasodilation; Vasopressins; Wounds, Nonpenetrating; Xanthine Oxidase | 2001 |
Hemodynamic effects of levcromakalim in neonatal porcine pulmonary hypertension.
Topics: Animals; Animals, Newborn; Blood Pressure; Cromakalim; Disease Models, Animal; Glyburide; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Ion Channel Gating; Potassium Channels; Streptococcus agalactiae; Swine; Vascular Resistance; Vasodilator Agents | 2001 |
The JT-area indicates dispersion of repolarization in dogs with atrioventricular block.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Body Surface Potential Mapping; Cromakalim; Disease Models, Animal; Dogs; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Block; Heart Conduction System; Heart Ventricles; Signal Processing, Computer-Assisted; Sulfonamides | 2002 |
Comparison of the effects of cromakalim in trachea isolated from normal and albumin-sensitive guinea-pigs.
Topics: Acetylcholine; Albumins; Animals; Asthma; Benzopyrans; Bronchodilator Agents; Cromakalim; Disease Models, Animal; Electric Stimulation; Flurbiprofen; Guinea Pigs; Immunization; In Vitro Techniques; Male; Potassium Channels; Pyrroles; Trachea | 1992 |
[The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
Topics: 4-Aminopyridine; Amifampridine; Animals; Benzopyrans; Coronary Vasospasm; Cromakalim; Disease Models, Animal; Dogs; Female; Glyburide; Guanidines; In Vitro Techniques; Ion Channel Gating; Male; Methylene Blue; Niacinamide; Nicorandil; Pinacidil; Potassium Channels; Pyrroles; Vasodilator Agents | 1992 |
Potassium channel activators cromakalim and celikalim (WAY-120,491) fail to decrease myocardial infarct size in the anesthetized canine.
Topics: Animals; Benzopyrans; Coronary Circulation; Coronary Vessels; Cromakalim; Disease Models, Animal; Dogs; Hemodynamics; Indoles; Myocardial Infarction; Perfusion; Potassium Channels; Pyrroles; Regional Blood Flow | 1992 |
Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
Topics: Animals; Benzopyrans; Disease Models, Animal; Potassium Channels, Inwardly Rectifying; Rats; Structure-Activity Relationship; Urinary Bladder; Urinary Incontinence, Urge | 2009 |